CTLA4 Promotes Tyk2-STAT3–Dependent B-cell Oncogenicity-Reference-Cited by-同舟云学术

CTLA4 Promotes Tyk2-STAT3–Dependent B-cell Oncogenicity

Published:2017-07-17 Issue:18 Volume:77 Page:5118-5128
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Herrmann Andreas,Lahtz Christoph,Nagao Toshikage,Song Joo Y.,Chan Wing C.,Lee Heehyoung,Yue Chanyu,Look Thomas,Mülfarth Ronja,Li Wenzhao,Jenkins Kurt,Williams John,Budde Lihua E.,Forman Stephen,Kwak Larry,Blankenstein Thomas,Yu Hua

Funder

Tim Nesvig Lymphoma Society

National Cancer Institute

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of SLC40A1 on Cytokine Interactions and Immune Infiltration in Glioblastoma;NeuroMolecular Medicine;2024-05-16

2. Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives;Experimental Hematology & Oncology;2024-04-23

3. Tumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy;Acta Pharmacologica Sinica;2024-04-12

4. Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma;Acta Pharmacologica Sinica;2024-04-12

5. Mechanism of Action and Pharmacologic Features of Drugs Targeting PD ‐1/ PDL ‐1 and CTLA ‐4;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21